Related Experiment Video
Updated: Jul 13, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling
Ingrid E Wertz1, Karen M O'Rourke, Honglin Zhou
1Department of Molecular Oncology, School of Medicine, University of California, Davis, Davis, California 95616, USA.
Abstract:
NF-kappaB transcription factors mediate the effects of pro-inflammatory cytokines such as tumour necrosis factor-alpha and interleukin-1beta. Failure to downregulate NF-kappaB transcriptional activity results in chronic inflammation and cell death, as observed in A20-deficient mice. A20 is a potent inhibitor of NF-kappaB signalling, but its mechanism of action is unknown. Here we show that A20 downregulates NF-kappaB signalling through the cooperative activity of its two ubiquitin-editing domains. The amino-terminal domain of A20, which is a de-ubiquitinating (DUB) enzyme of the OTU (ovarian tumour) family, removes lysine-63 (K63)-linked ubiquitin chains from receptor interacting protein (RIP), an essential mediator of the proximal TNF receptor 1 (TNFR1) signalling complex. The carboxy-terminal domain of A20, composed of seven C2/C2 zinc fingers, then functions as a ubiquitin ligase by polyubiquitinating RIP with K48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation. Here we define a novel ubiquitin ligase domain and identify two sequential mechanisms by which A20 downregulates NF-kappaB signalling. We also provide an example of a protein containing separate ubiquitin ligase and DUB domains, both of which participate in mediating a distinct regulatory effect.
Insights
A20 protein inhibits chronic inflammation by removing and adding ubiquitin chains to RIP, a key signaling molecule. This dual action targets RIP for degradation, downregulating NF-kappaB signaling and preventing cell death.
Area of Science:
- Molecular Biology
- Immunology
- Biochemistry
Background:
- NF-kappaB transcription factors are crucial mediators of pro-inflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1beta.
- Dysregulated NF-kappaB activity leads to chronic inflammation and cell death, as evidenced in A20-deficient mice.
- A20 is recognized as a potent inhibitor of NF-kappaB signaling, yet its precise mechanism of action remained elusive.
Purpose of the Study:
- To elucidate the mechanism by which A20 downregulates NF-kappaB signaling.
- To characterize the distinct roles of A20's ubiquitin-editing domains in regulating inflammatory pathways.
- To identify novel ubiquitin ligase domains and sequential regulatory mechanisms.
Main Methods:
- Investigated the enzymatic activities of A20's N-terminal de-ubiquitinating (DUB) and C-terminal ubiquitin ligase domains.
- Analyzed the ubiquitination status of receptor interacting protein (RIP) in response to TNF receptor 1 (TNFR1) signaling.
- Utilized proteasomal degradation assays to assess the fate of RIP.
Main Results:
- A20's N-terminal OTU domain removes K63-linked ubiquitin chains from RIP.
- A20's C-terminal zinc finger domain polyubiquitinates RIP with K48-linked chains, targeting it for proteasomal degradation.
- Demonstrated a novel mechanism of NF-kappaB downregulation through sequential ubiquitin editing of RIP.
Conclusions:
- A20 employs a dual ubiquitin-editing strategy involving de-ubiquitination and subsequent polyubiquitination of RIP.
- This coordinated action effectively terminates NF-kappaB signaling, preventing chronic inflammation.
- Highlighted A20 as a key example of a protein with distinct DUB and ubiquitin ligase domains mediating specific regulatory functions.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

